- All Drug Categories
- Home
- Anti-cancer Drugs
- Healthcare Products
- Medical Information
- Statement
Sorafenib is a multi kinase inhibitor primarily used for the treatment of liver cancer, kidney cancer, and thyroid cancer. Its common side effe...
Sorafenib is a multi kinase inhibitor mainly used for the treatment of advanced liver and kidney cancer. Its use should focus on liver toxicity...
Sorafenib, as a multi kinase inhibitor, has clear contraindications, dietary restrictions, and special condition requirements for its use. The ...
The standard usage of Sorafenib is twice daily oral administration, taken on an empty stomach. For special populations, the dosage should be ad...
Dasatinib is a tyrosine kinase inhibitor primarily used for the treatment of hematological malignancies with specific gene mutations. Its use r...
Ocaliva, as a therapeutic drug for primary biliary cholangitis, mainly has side effects on the liver and gallbladder system, metabolic abnormal...
Ocaliva is a medication used for specific liver diseases, and its indications and medication precautions must strictly follow clinical guidelin...
The contraindications of Ocaliva involve specific disease states, physiological stages, and dietary restrictions, and must be strictly followed...
Ocaliva is a farnesol X receptor agonist primarily used for the treatment of primary biliary cholangitis (PBC). The following provides detailed...
The contraindications and use of Brigatinib in special populations must strictly follow clinical guidelines, involving risk management for spec...
